ARCHIVES

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Rimer, Boxer Reappointed to NCAB; 4 Others Named

June 28, 1996

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995